European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines
JA Witjes, HM Bruins, R Cathomas, EM Compérat… - European urology, 2021 - Elsevier
Context This overview presents the updated European Association of Urology (EAU)
guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …
guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …
(Nano) platforms in bladder cancer therapy: Challenges and opportunities
M Ashrafizadeh, A Zarrabi… - Bioengineering & …, 2023 - Wiley Online Library
Urological cancers are among the most common malignancies around the world. In
particular, bladder cancer severely threatens human health due to its aggressive and …
particular, bladder cancer severely threatens human health due to its aggressive and …
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm …
AV Balar, AM Kamat, GS Kulkarni, EM Uchio… - The Lancet …, 2021 - thelancet.com
Background Standard treatment for high-risk non-muscle-invasive bladder cancer is
transurethral resection of bladder tumour followed by intravesical BCG immunotherapy …
transurethral resection of bladder tumour followed by intravesical BCG immunotherapy …
Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle …
C Pfister, G Gravis, A Fléchon, C Chevreau… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The optimal perioperative chemotherapy regimen for patients with nonmetastatic
muscle-invasive bladder cancer is not defined. PATIENTS AND METHODS Between …
muscle-invasive bladder cancer is not defined. PATIENTS AND METHODS Between …
Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System)
V Panebianco, Y Narumi, E Altun, BH Bochner… - European urology, 2018 - Elsevier
Context Management of bladder cancer (BC) is primarily driven by stage, grade, and
biological potential. Knowledge of each is derived using clinical, histopathological, and …
biological potential. Knowledge of each is derived using clinical, histopathological, and …
Bladder cancer
O Sanli, J Dobruch, MA Knowles, M Burger… - Nature reviews Disease …, 2017 - nature.com
Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin, or gemcitabine and cisplatin as perioperative chemotherapy for …
C Pfister, G Gravis, A Fléchon, M Soulié, L Guy… - European Urology, 2021 - Elsevier
Background Perioperative chemotherapy (neoadjuvant or adjuvant) has been developed to
increase overall survival for nonmetastatic muscle-invasive bladder cancer (MIBC) …
increase overall survival for nonmetastatic muscle-invasive bladder cancer (MIBC) …
Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies
A Necchi, D Raggi, A Gallina, R Madison, M Colecchia… - European urology, 2020 - Elsevier
Background Patients with predominant variant histology (VH) of bladder tumors, defined as
involving> 50% of the tumor specimens, are typically excluded from clinical trials, and for …
involving> 50% of the tumor specimens, are typically excluded from clinical trials, and for …
[HTML][HTML] Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of> 2 …
Background Novel second-line treatments are needed for patients with advanced urothelial
cancer (UC). Interim analysis of the phase III KEYNOTE-045 study showed a superior overall …
cancer (UC). Interim analysis of the phase III KEYNOTE-045 study showed a superior overall …
Circ HIPK 3 sponges miR‐558 to suppress heparanase expression in bladder cancer cells
Y Li, F Zheng, X Xiao, F Xie, D Tao, C Huang, D Liu… - EMBO …, 2017 - embopress.org
Increasing evidences suggest that circular RNA s (circ RNA s) exert crucial functions in
regulating gene expression. In this study, we perform RNA‐seq and identify 6,154 distinct …
regulating gene expression. In this study, we perform RNA‐seq and identify 6,154 distinct …